You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 17, May 6, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Pain
 •Substance Abuse/ Alcoholism
 •Quality of Care
 •Patient Safety/ Medical Error
 •Drug Therapy
 •Adverse Effects
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prescription Opioids and Overdose Deaths—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: We agree with the emphasis by Ms Graham and colleagues on methadone. According to mortality data reported by the National Center for Health Statistics, methadone appears to be involved in more drug-overdose deaths than heroin or any other prescription opioid.1 We also appreciate the need for surveillance systems that can provide more timely and detailed data on drug overdoses than those from existing systems. Despite the rapid reporting of basic information on drug-related deaths in a few states, including Florida,2 obtaining just as timely and more detailed data nationwide will be challenging because of the existing demands on coroners and medical examiners and the notoriously low reporting rates in passive public health surveillance systems.3 Establishment of uniform data elements and electronic records systems for coroners and medical examiners might circumvent these barriers.

We agree with Dr Layne and colleagues on the value of institutional policies on the use . . . [Full Text of this Article]

Aron J. Hall, DVM, MSPH
ajhall@cdc.gov

Leonard J. Paulozzi, MD, MPH
Centers for Disease Control and Prevention
Atlanta, Georgia



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Patterns of Abuse Among Unintentional Pharmaceutical Overdose Fatalities
Aron J. Hall, Joseph E. Logan, Robin L. Toblin, James A. Kaplan, James C. Kraner, Danae Bixler, Alex E. Crosby, and Leonard J. Paulozzi
JAMA. 2008;300(22):2613-2620.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Prescription Opioids and Overdose Deaths
Noni A. Graham, Mark S. Gold, and Bruce A. Goldberger
JAMA. 2009;301(17):1766.
EXTRACT | FULL TEXT  

Prescription Opioids and Overdose Deaths
Richard D. Layne, Ronald J. Pellegrino, and Nathan M. Lerfald
JAMA. 2009;301(17):1766-1767.
EXTRACT | FULL TEXT  

Prescription Opioids and Overdose Deaths
Robert Newman
JAMA. 2009;301(17):1767.
EXTRACT | FULL TEXT  

Prescription Opioids and Overdose Deaths
Michael Merrick
JAMA. 2009;301(17):1767.
EXTRACT | FULL TEXT  

Prescription Opioids and Overdose Deaths—Reply
A. Thomas McLellan and Barbara J. Turner
JAMA. 2009;301(17):1768-1769.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.